JOURNAL OF HEPATOLOGY Journal
Overview
publication venue for
- GL0034 (Utreglutide), a long acting, glucagon-like peptide-1 receptor agonist, improves body weight loss, lipid and liver injury markers in individuals with obesity: A phase 1 multiple ascending dose study 2024
- Interim safety results of the ongoing international phase I/II GATEWAY gene therapy trial with VTX-801 conducted in adult patients with Wilson disease 2024
- Maralixibat improves growth in patients with progressive familial intrahepatic cholestasis: data from the MARCH/MARCH-ON trials 2024
- Analysis of safety in maralixibat-treated participants with progressive familial intrahepatic cholestasis: data from MARCH-PFIC 2023
- GL0034 (Utreglutide), a novel, long acting, glucagon-like peptide 1 receptor agonist (GLP-1 RA), results of a phase 1 study in healthy individuals 2023
- Long-term maintenance of response and improved liver health with maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC): data from the MARCH-ON study 2023
- GL0034, A novel long-acting glucagon-like peptide 1 receptor agonist exhibits significant efficacy in aged db/db mouse model of non-alcoholic fatty liver disease (NAFLD) 2022
- Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study. 70:885-892. 2019
- NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R) 2015
- Structural and inflammatory heterogeneity in subcutaneous adipose tissue: Relation with liver histopathology in morbid obesity. 56:1152-1158. 2012
- PATHOGENETIC MECHANISMS OF HEPATOCELLULAR DAMAGE IN CHRONIC HEPATITIS-C VIRUS-INFECTION 1994
Research
category
- GASTROENTEROLOGY & HEPATOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0168-8278
Electronic International Standard Serial Number (EISSN)
- 1600-0641
Other
journal abbreviation
- J HEPATOL